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Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human
renal disease? Tubular lipidosis is a commonly observed histological
lesion in proteinuric renal diseases. We have studied the interaction
between native and modified human lipoproteins and human renal
proximal tubular cells to investigate whether lipoproteins could be
injurious to tubular cells in culture. Human renal proximal tubular cells
were cultured and characterized by established methods. Preliminary
studies showed that these cells could take up and degrade normal
human lipoproteins by high affinity (HDL) and low affinity (LDL)
pathways. In subconfluent culture, native lipoproteins, that is, LDL,
HDL2 and HDL3, had markedly different effects on cell growth as
measured by 3H-thymidine uptake and total cell protein as compared to
modified lipoproteins such as minimally modified and oxidized LDL. In
addition, we found that renal tubular cells could oxidize native LDL in
the presence of copper largely by a superoxide-mediated mechanism.
Finally, cellular accumulation of lipid was demonstrated in vitro by
incubating cultured cells with varying lipoprotein concentrations for up
to 48 hours. Notably, cell detachment was observed only with high
concentrations of modified LDL especially with minimally modified
LDL. We speculate that uptake and oxidation of filtered LDL by
tubular cells may lead to tubular injury in nephrotic states.
It is not known how much lipoprotein is normally filtered by
the kidney. For instance, HDL-like particles have been de-
tected in concentrated human urine albeit at a higher density
range (d > 1.24) than plasma HDL (d = 1.063 to 1.21) [1].
However, what appears in the urine is probably only a fraction
of what is filtered. For example, it has been estimated that up to
3 g of albumin is normally filtered by the kidney in 24 hours but
only 30 mg appear in the urine [2].
Several studies have pointed to the fact that unlike normal
urine, significant quantities of HDL and lesser amounts of LDL
as well as other lipoproteins [3—5] are excreted in nephrotic
urine. HDL is the main urinary lipoprotein regardless of serum
lipid concentrations, presumably because of its smaller size [4].
In one study, the urinary concentration of Apo-Al, the main
apoprotein of HDL, measured using a specific and sensitive
immunoassay averaged 38.4 mg/liter in nephrotic patients but
was more than a thousandfold less at 16.3 /Lglliter in normal
controls [6]. The intrarenal handling of ifitered lipoproteins is
unclear. However, they are probably reabsorbed and catabo-
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lized by the proximal tubule as has been shown for HDL3 in
rabbit kidney [7].
There is already a large body of evidence to implicate
proteinuria as an independent risk factor in renal disease
progression [8]. In pathological states, the major component of
urine protein is albumin, but it seems unlikely that albuminuna
per se is damaging to tubular cells since minimal change disease
which is characterized by heavy and sometimes prolonged
albuminuria does not lead to progressive tubulointerstitial dam-
age [9]. Moreover, the putative mechanisms by which albumin-
una might be damaging are unconvincing [10, 11]. Thus, it is
possible that other filtered plasma proteins may account for the
pathogenetic role of proteinuria in progression [9]. Further-
more, the known association of acute tubular necrosis with
severe nephrotic states, such as with focal segmental glomeru-
lar sclerosis (FSGS), has usually been ascribed to renal hypo-
perfusion but may be due in part to the tubular toxicity of
filtered plasma proteins [2]. Significant lipiduria clearly does
occur in nephrotic states [12], but the potential toxicity of
filtered lipoproteins to renal tubular cells has not been previ-
ously examined. Because of species differences for plasma
lipoproteins in terms of their normal ratio in plasma [13] and
their binding characteristics [14], we chose a human in vitro
model of tubular lipidosis as the most relevant model for the
study of the interaction between filtered lipoproteins and prox-
imal tubular cells.
Methods
Cell culture and characterization
Human renal cortical epithelial cells were grown as previ-
ously described from grossly normal renal cortical tissue ob-
tained at nephrectomy or from cadaveric kidneys considered
unsuitable for transplantation [15]. The cells were grown on
collagen-coated flasks in serum-free hormonally supplemented
medium [16] except for the first seven days of culture (5%
Nu-serum added). This medium has been found to optimize the
growth of human renal tubular cells under serum-free condi-
tions [16].
Tubular cells cultured under these conditions were charac-
terized as a highly enriched population of proximal tubular
origin according to previously published methods: ultrastruc-
turally by light and electron microscopy, enzyme histochemis-
try, immunocytochemistry and sodium-dependent glucose
transport [16—18]. Under light microscopy, the cells were of
epithelial morphology with a cobblestone appearance. When
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confluent, they formed domes typical of transporting epithelia.
By electron microscopy, features typical of proximal tubular
epithelia (that is, abundant apical microvilli, mitochondria,
endocytic vacuoles and tight junctions) were seen. The cells
showed positive surface staining for alkaline phosphatase by
the method of Rutenburg and positive intracellular staining for
cytokeratin by immunoperoxidase [19]. There was negative
staining for factor Vill-related antigen showing the absence of
endothelial cells. Sodium-dependent glucose transport was
studied using [14C] a-methyl glucopyranoside (AMG), a non-
metabolizable analogue of D-glucose, whose uptake by the
sodium-glucose cotransporter is specifically inhibited by phlo-
rizin. At one hour, AMG uptake was inhibited to a mean of
52.3% (range 47.7 to 58.2%) in three separate determinations by
0.1 mM phlorizin, similar to the findings of Chung et al [20] for
rabbit proximal tubular cells and Kempson et a! [17] for human
proximal tubular cells.
Preparation of lipoproteins
Human HDL (d = 1.063 to 1.21 glml), HDL2 (d = 1.063 to
1.125 g/ml), HDL3 (d 1.125 to 1.21 gIml) and LDL (d = 1.019
to 1.063 g/ml) were obtained by differential ultracentrifugation
flotation of plasma from two normal healthy volunteers as
previously described [21]. The isolated fractions were concen-
trated by further ultracentrifugation and dialyzed extensively
against buffer containing 0.15 M phosphate buffered saline
(PBS) and 0.1 m EDTA. LDL used for oxidation was dialyzed
against EDTA-free buffer before the addition of copper sulphate
(10 M) as previously described [22]. Minimally modified LDL
was generated by prolonged storage of native LDL at 4°C [23].
Thiobarbituric acid reactive substances (TBARS) in the frac-
tions were measured as an indicator of the degree of oxidation
[24]. Oxidized LDL was defined as fractions with TBARS of
>15 nmol malondialdehyde (MDA) equivalents per mg protein,
minimally modified LDL as those with TBARS of 1 to 5 nmol
MDA equivalents per mg protein, and non-oxidized LDL as
those with TBARS of <0.1 nmol MDA equivalents per mg
protein [25]. Lipoprotein fractions were also assessed by
changes in electrophoretic mobility on agarose gel (0.7%)
electrophoresis [26]. The free radical scavenger, butylated
hydroxytoluene (BHT, 20 M) was subsequently added to both
native and modified LDL as an antioxidant. The purity of
isolated lipoprotein fractions was assessed by their apoprotein
content: HDL and LDL preparations contained less than 1 mg
of apo-B and apo-Al per 100 mg total protein, respectively, as
measured by an immunoturbidimetric assay (Technicon RA).
All lipoprotein fractions were filtered through a 0.22 j.tm filter
immediately prior to use.
Degradation of lipoproteins
Cellular lipoprotein degradation was determined by measur-
ing the appearance of 1251-iodotyrosine in cell supernatants over
time at 37°C as previously described [27]. Freshly isolated
lipoproteins (LDL and HDL) were iodinated using lactoperox-
idase and glucose oxidase enzymes immobilized on hydrophilic
spheres (Enzymobead radioiodination reagent, Biorad Labora-
tories Ltd, Hemel Hempstead, UK). N&251 was obtained from
Amersham International plc (Aylesbury, Bucks, UK). Un-
bound iodine was removed by passage through a quarternary
aminoethyl Sephadex 050 Column (Pharmacia, UK) and ex-
haustively dialyzed against phophate buffered saline (pH 7.4).
Ninety to 99% of the radioactive material was precipitable using
20% trichloroacetic acid (TCA). Radiolabeled lipoprotein prep-
arations were sterilized by passage through a 0.22 pm filter
immediately prior to use.
Cells were exposed to incubation medium containing 15
pg/ml of '251-LDL or 1251-HDL. At predetermined time inter-
vals (15, 30, 45, 60, 120, 180 and 240 mm of incubation) dishes
were cooled on ice and 0.7 ml of incubation medium with 0.1 ml
of pooled human plasma added to tubes containing 2 ml of 14%
trichloroacetic acid. Tubes were then centrifuged, incubated on
ice for 30 minutes and 2 ml of the supernatant added to 1 ml of
5% AgNO3 solution. After pelleting the silver halide precipitate,
aliquots of supernatant were saved to measure 125jradioactivity
and the cells dissolved in 0.5 M NaOH for protein estimations
[28]. Degradation was expressed as ng '251-LDL or '251-HDL
degraded per mg cell protein after subtracting any lipoprotein
degradation in the absence of cells. Specific activity for HDL
was 33.83 cpmlng protein and for LDL, 46.25 cpm/ng protein.
Oil-red-O staining
Human renal proximal tubular cells were grown to conflu-
ency on chamber tissue culture slides (Labtek, Nunc) and
incubated with a range of concentrations of human plasma
lipoproteins: HDL3 (100 to 4000 j.&g/ml), LDL (100 to 4000
gIml), minimally oxidized LDL (100 to 3000 gIml) and
oxidized LDL (100 to 1000 gIml) for up to 48 hours. The cells
were washed twice with ice-cold PBS and then fixed with 10%
neutral-buffered formalin for one hour. Intracellular lipid was
stained with oil-red-O and nuclei with hematoxylin. Detached
cells were pelleted by centrifugation, resuspended in 0.5 ml of
PBS and plated onto a glass slide, air dried and then stained as
above.
[3HJ thymidine uptake
Cells were plated into 96 well plates at subconfluent density
and exposed to "arrest medium" (RPMI 1640 supplemented
with antibiotics only) for 48 hours to synchronize the growth
phase of all cells to G0. Lipoprotein containing medium was
then added to triplicate or quadruplicate wells at various
concentrations for 72 hours; [3H] thymidine (Amersham) was
added to each well (1 MCi) 18 hours before the end of the
experiment. The cells were washed, trypsinized and harvested
onto filter paper using an automatic cell harvester. The amount
of [3H] thymidine incorporated into cellular DNA was then
estimated by liquid scintillation counting in a beta counter.
Results are expressed as percent control to enable comparison
between different experiments.
Total cell protein
Cells were plated at subconfluent density (5 x l0 to 2 x l0
cells per 25 cm2 flask) in basal growth medium. Mter 48 hours,
this was replaced with lipoprotein containing medium at differ-
ent concentrations in triplicate (day 0). Fresh lipoprotein-
containing medium was added at the same concentrations to
each flask after 48 hours (day 3). The cells were then solubilized
in 0.5 M NaOH for a protein assay at day 5 [28]. To enable
comparison between different experiments, total cell protein
was calculated as gIflask and expressed as a percentage of
control flasks which received only serum-free medium.
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Fig. 1. Cellular lipoprotein degradation over four hours, measured as
trichioroacetic acid (TCA) soluble radioactivity. Symbols are: ()
LDL; (A) HDL. Each point represents the mean of four determina-
tions.
Cellular oxidation of LDL
Human renal proximal tubular cells were plated at high
density into 12 well plates. After 48 hours, the cells were 80%
confluent. Freshly isolated LDL was added (200 gIml) in the
presence and absence of copper sulphate (5 SM), superoxide
dismutase (SOD, 100 gIml), 5,8,11, l4-eicosatetraynoic acid
(ETYA, 20 /LM) and nitro-L-arginine methylester (L-NAME, 10
/LM) for 24 hours. Preliminary experiments showed that this
concentration of copper sulphate does not affect tubular cell
viability over a 24 hour period (data not shown) and is consis-
tent with the data of other workers using different cell systems
[29]. Identical cell-free wells were set up simultaneously as
controls. Oxidation was terminated by the addition of BHT (20
LM) and EDTA (5 tM). The degree of oxidation of LDL was
then assessed by TBARS estimation [24].
Materials
Tissue culture medium was obtained from Gibco (Paisley,
Scotland, UK) and chemicals from Sigma (Poole, Dorset, UK)
unless otherwise stated. Tissue culture flasks and plates were
obtained from Falcon (Becton Dickinson, Cowley, UK), ben-
zylpenicillin from Glaxo, bovine dermal collagen (vitrogen 100)
from Collagen Corporation (Palo Alto, California, USA), Nu-
serum from Collaborative Research Inc. (Bedford, Massachu-
setts, USA), and 0.22 m biological filters from Millipore
(Watford, Herts, UK).
Results
Degradation of lipoproteins
The appearance of 1251 iodotyrosine in cell supernatants over
time demonstrated that these cells could take up and degrade
LDL and HDL (Fig. 1). 125! iodotyrosine could be clearly
detected by 30 minutes for LDL and 60 minutes for HDL. There
was, however, a clear difference in the magnitude of degrada-
tion between LDL and HDL at all time periods. By four hours,
lipoprotein degradation had reached 2809 ng/mg cell protein for
LDL and 413 ng/mg cell protein for HDL. Counts for "no cell"
blanks represented only 0.2% of total added radioactivity.
Oil-red-O (ORO) staining
Both confluent and non-confluent cell layers accumulated
intracellular lipid in a dose-dependent manner upon incubation
with both native and altered human plasma lipoproteins as
shown by positive ORO staining. Of note, no cell detachment
was seen with native lipoproteins (HDL3, LDL) even after
prolonged incubation (48 hr) at high concentrations (4000 g/ml;
Fig. 2 a,b). In contrast, oxidative cell damage was seen in
subconfluent areas after incubation with oxidized LDL for 24
hours even at low concentrations (100 g/ml) (data not shown).
In confluent cultures, however, oxidative cell damage was not
seen but cell detachment (albeit partial) still occurred after a 24
hour incubation with oxidized LDL at high concentration (1000
pg!ml; Fig. 2c). Incubation of both confluent and subconfluent
cultures with minimally oxidized LDL resulted in cell rounding
(1000 gIml) and complete cell detachment (2000 g/ml) by two
hours (Fig. 2d). Detached cells were invariably highly ORO
positive with marked intracellular lipid accumulation (Fig. 2d).
Interestingly, no cell detachment was observed with cell mono-
layers incubated with lower concentrations (500 g/ml or less)
of minimally modified LDL in spite of prominent intracytoplas-
mic lipid accumulation (data not shown). Cells incubated with
lipoprotein-free defined medium (Fig. 2e) or delipidated bovine
serum albumin (1000 gIml) (Fig. 20 showed no significant
ORO positivity.
[3H] thymidine uptake
There was a roughly twofold maximal stimulation at 500
g/ml lipoprotein followed by a decrease in stimulated thymi-
dine uptake at 5000 /Lg/ml lipoprotein for both HDL2 and HDL3.
At all concentrations tested, there was no significant difference
in thymidine uptake between HDL2 and HDL3 (Fig. 3, Table 1).
A decrease in thymidine uptake was observed with both HDL2
and HDL3 at concentrations of 5000 tgIml; this was not
significantly different from thymidine uptake by the cells at
concentrations of 1000 gIml.
A similar pattern of dose-dependent stimulation at low ii-
poprotein concentrations (10 to 1000 g/ml) and a non-signifi-
cant decrease in stimulation at high lipoprotein concentrations
(5000 jg/ml) was observed with native LDL (Fig. 4). In
contrast, a dose-dependent decrease in thymidine uptake (10 to
1000 pg/ml) associated with cell necrosis and detachment (500
to 1000 tgIml) was seen following incubation with oxidized
LDL (Fig. 4). Cells incubated in parallel for 24 hours with
oxidized LDL showed decreased cell viability, as assessed by
Trypan blue exclusion: 2% (200 gIml) and 0% (500 gIml).
Compared with LDL, smaller increases in thymidine uptake
were seen with minimally modified LDL at all concentrations
up to 500 tgIml, following which thymidine uptake decreased in
association with cell detachment (1000 p.gIml; Fig. 5). Cell
viability, as assessed by Trypan blue exclusion, also decreased
to 33% after a 24 hour incubation with minimally modified LDL
at concentrations of 1000 tg/ml but was 90 to 100% at concen-
trations at or below 500 jg/ml.
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Fig. 2. Photomicrographs (magnification) of lipid-laden tubular cells following incubation with: (a) 4 mg/mi HDL3 for 48 hours (phase x400), (b)
4 mg/mI native LDL for 48 hours (phase X400), (c) 1 mg/mI oxidized LDL for 24 hours (phase x400); note the partial cell detachment from a
confluent cell monolayer, (d) 2 mg/mI minimally modified LDL for 24 hours (phase, oil x 1000); detached cells were air dried onto glass slides and
stained with ORO as described in the Methods section. Note the prominent intracytoplasmic inclusions. In contrast, no intracytoplasmic inclusions
were seen in cells incubated with (e) defined medium (control) (X400) or (f) delipidated BSA (x400) for 24 hours.
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Fig. 3. 3H-thymidine uptake in response to HDL2 (0) and HDL3 (S) as
compared with lipoprotein-free controls. Lipoprotein concentration is
expressed as g protein/mi on a logarithmic scale (25 to 5000 g/ml).
Each point represents the mean sa of four determinations and is
significantly different from control (P < 0.05, two-sample t-test). There
was no significant difference between HDL2 and HDL3 at each concen-
tration tested.
Table 1. [3H]-thymidine incorporation in human PTC after a 72 hours
incubation with different concentrations of HDL2 and HDL3
Lipoprotein protein
concentration
jg/ml
[3H]-thymidine incorporation
cpm, % control
HDL2 HDL3
10 140.97 8.18 157.10 7.69
50 152.53 4.81 163.94 3.42
100 156.45 4.60 169.84 5.96
200 178.01 7.29 176.28 4.66
500 208.50 14.09 207.65 7.92
1000 220.35 9.58 202.82 3.98
5000 192.06 21.89 186.93 9.44
* * *
1 I
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Fig. 4. Changes in DNA synthesis as measured by 3H-thymidine
uptake in response to LDL () and oxidized LDL (A; ox-LDL), in the
concentration range 10 to 1000 sg/ml, expressed as a percentage of
lipoprotein-free controls (100%). Each point represents the mean SE
of four determinations (*P < 0.05 wrt ox LDL). For both LDL and
ox-LDL, points at or above 200 jsg protein/mi were significantly
different from control (P < 0.05, two-sample t-test).
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Fig. 5. Changes in DNA synthesis as measured by thymidine uptake in
cells exposed to native LDL (Li) or minimally modfIed (A; mox-LDL) at
concentrations of 10 to 1000 pg/m!, expressed as a percentage of
control. Each point represents the mean 5E of four determinations
(*O < 0.05 wrt mox-LDL). Note the smaller increase in thyniidine
uptake seen with mox-LDL, as compared to LDL, at all concentrations
tested.
cell damage was seen in the presence of superoxide dismutase
(Fig. 6a). In the absence of copper, superoxide dismutase
appeared paradoxically to promote cellular LDL oxidation
although the effect was small. Since superoxide dismutase
stabilizes nitric oxide (NO), (NO) which is itself a weak oxidant
[30] and which has been shown to be produced by tubular cells
[31], the effect of co-incubation with L-NAME, an inhibitor of
NO synthase was examined in parallel. L-NAME did not
abolish this pro-oxidant effect of superoxide dismutase, thus
showing that nitric oxide was not responsible. In endothelial
cells the 15-lipoxygenase system has been implicated in LDL
oxidation [29]. This system is specifically inhibited by ETYA.
Total cell protein
Consistent with the data on thymidine uptake, both HDL and
LDL stimulated cell growth as measured by total cell protein
per flask. There was no significant difference between the
maximal growth stimulation produced between both lipopro-
teins (171.7 10.9% vs. 162.3 5.4%). No difference in cell
growth compared with controls was observed over five days at
the highest HDL concentration (4.0 m cholesterol, 8.5 mg/mI
protein). This sharp decrease in total cell protein (Table 2) was
greater than the maximal decrease in thymidine uptake ob-
served, albeit at lower HDL concentrations (5 mg/mi; Table 1),
and may in part reflect the different experimental designs
employed.
Cellular oxidation of LDL
In the presence of trace amounts of copper, significant
cellular oxidation of LDL was observed, associated with
marked oxidative cell damage with membrane blebbing and cell
detachment as in the thymidine uptake experiments (Fig. 6b,
Table 3). Of the compounds tested, only supei-oxide dismutase
inhibited LDL oxidation appreciably (up to 75%) and although
this inhibition was only partial, little histological evidence of
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Table 2. Effect of HDL and LDL on tubular cell growth measured as
changes in total cell protein over five days
Lipoprotein cholesterol
concentration (mM)ab
Cell protein per flask
g/fiask, % control
HDL LDL
(N = 6) (N = 3)
0.25 138.6 3.8 106.6 1.9
0.50 135.1 4.9 115.3 8.5
0.75 171.7 10.9 130.5 4.0
1,00 170.0 2.6 162.3 5.4
2.00 165.5 12.2 155.8 14.5
4.00 107.7 13.6C 154.8 10.0
a 1 mi HDL cholesterol is equivalent to 1.71 mg/mi HDL protein
b 1 mat LDL cholesterol is equivalent to 0.33 mg/mi LDL protein
C All values significantly different from control (P < 0.05) except
HDL cholesterol 4.0 mat (P > 0.05)
Our results, however, showed that ETYA had no effect on LDL
oxidation by tubular cells.
Discussion
The possibility that filtered lipoproteins are toxic to proximal
tubular cells in high concentration (as in heavy proteinuric
states) and thus promote progressive tubulointerstitial disease
is intriguing but has not been fully explored [32]. Yet as early as
1913, Munk had coined the term "lipoid nephrosis" because he
had observed fat bodies in the urine and fatty changes in the
tubules of nephrotic patients. He concluded that a "generalized
metabolic disorder involving fat metabolism" was the cause
[33].
Evidence that tubular uptake of filtered lipoproteins occurs in
humans comes from several observations. Nephrotic urine
often contains numerous lipid-laden tubular cells [2]. Intracy-
toplasmic lipid droplets in tubular cells have been demonstrated
in renal biopsies from nephrotic patients by electron micros-
copy [34]. Furthermore, immunohistochemical staining of renal
biopsies from nephrotic patients has shown the presence of
apoA and apoB, the major apoproteins of HDL and LDL,
respectively, in tubular cells and the renal interstitium [35]. It is
unlikely though that there is much lipoprotein ifitered in mini-
mal change disease, although to date this question has been
addressed in only one study [36]. Cellular lipid accumulation in
this condition is probably due to the metabolism of albumin-
complexed fatty acids to neutral lipids [37]; in this setting,
albumin may be considered as a "lipoprotein."
Precise estimates for the amount of filtered lipoprotein in
nephrotic states are unavailable, but if it is assumed that like
albumin only 1% of the filtered protein load appears in the urine
[2], then the average protein concentration of filtered HDL
could, for instance, be around 4 mg/mi [6]. This fits in well with
a study of two nephrotic patients where calculated estimates of
filtered LDL and HDL2 protein concentrations averaged 4
mg/mi and those of HDL3 averaged 8 mg/mi [4].
Our first study clearly showed that both HDL and LDL could
be taken up and degraded by the cells albeit to different extents.
Although lipoprotein binding was not specifically examined,
these two patterns of degradation are suggestive of high affinity
(LDL) and low affinity (HDL) uptake [38]. Human renal prox-
imal tubular cells appear to possess both receptor and non-
receptor mediated mechanisms for LDL uptake [39]. There is
evidence that tubular cells possess apical LDL receptors [40,
41] but there is disagreement as to the characteristics and
function of these receptors [40—42].
HDL receptors have yet to be fully characterized [43] and
their presence or absence on human tubular cells is unknown at
present. Nonetheless, our data on HDL degradation would
suggest either a non-receptor mediated mechanism or a low-
affinity HDL receptor subtype. Luminal HDL3 uptake can
occur in the rabbit straight proximal tubule [7] and this implies
a mechanism for reclaiming normally filtered HDL3. Indeed, if
HDL is normally filtered [1], this may be a means of delivering
cholesterol to proximal tubular cells [7] in an analogous way as
to adrenal and ovary [13], since these cells probably have a
higher cholesterol requirement because of their rapid turnover
of plasma membrane [44].
However, regardless of the mode of uptake, it is likely that in
nephrotic states, proximal tubular cells may become "overload-
ed" with filtered lipoproteins thus giving rise to the character-
istic lipid-laden tubular cells. This profound intracellular lipid
accumulation has been assumed to be potentially toxic to the
cells [7, 32] but has not been previously examined. Using ORO
staining as a marker of lipoprotein uptake, we were able to
generate lipid-laden tubular cells in vitro by incubating the cells
with both normal and modified lipoproteins. Of note, marked
cellular lipid accumulation was observed with high concentra-
tions of native HDL3 and LDL without morphological cell
injury (Fig. 2a, b) but incubation with modified LDL, that is,
either oxidized (Fig. 2c) or minimally modified LDL (Fig. 2d),
resulted in oxidative cell injury and detachment of highly
lipid-laden cells. We were unable to examine apical and baso-
lateral lipoprotein uptake separately, as we could not generate
sufficiently impermeant cell monolayers (as measured by trans-
membrane electrical resistance and [14C]-inulin permeability).
It is likely though that they are different, as other workers have
found in other polarized cells [40, 42].
Our results on the effect of HDL and LDL on cell growth
assessed in two different ways show that growth inhibition only
occurred at lipoprotein concentrations of 5000 tg/ml or greater.
Furthermore, there was no difference between HDL2 and
HDL3; because of its smaller size, relatively more HDL3 should
be filtered in nephrotic states [45]. These findings are consistent
with previous work on MDCK cells for HDL [46]. However,
unlike others in other renal cells [21, 46], we did not find native
LDL to be toxic to human proximal tubular cells even at high
concentrations. It is possible that this reflects the unique
capacity of proximal tubular cells to handle a high load of
filtered proteins normally [47]. Alternatively, it is possible that
small differences in lipid peroxidation which were not measured
in earlier studies account for the observed toxicity of native
LDL. The mitogenic and cytotoxic effects of LDL on MDCK
cells [46] are in fact remarkably similar to our findings with
minimally modified LDL. This will be discussed further below.
In contrast, the pattern of growth stimulation and inhibition
seen with modified LDL is very different to that seen with
normal LDL. Cell detachment was observed with both oxidized
and minimally modified LDL at lipoprotein concentrations of
500 pg/ml and 1000 tgfml, respectively. Brief or extensive
oxidation of native LDL is known to lead to the accumulation of
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Fig. 7. E15 rat lung labeled with 2b-l1 antisenxe probe. Grains are most abundant over developing airway epithelium. Much less hybridization is observed
over surrounding mesenchyme.
Fig. 8. E15 rat kidney labeled with 2b-1l anti-sense probe. (A) Grains are most numerous over the comma-shaped bodies (arrows) but are also frequent
over ureteric buds (arrowheads). (B) Higher power view of S-shaped figure showing intense hybridization over early proximal (P) and distal (D) tubule
segments, with somewhat less labeling seen over visceral epithelial cells (arrows).
Fig. 9. Low (A) and higher power (B) micrographs of 3-d-old rat kidney labeled with 2b-11 anti-sense probe. Note that the most numerous grains overlie
early nephric structures in extreme cortex (arrowheads) as well as glomeruli (arrows). Hybridization is also present over collecting ducts (C) but tubular
and interstitial areas are generally negative. Reproduction of these figures in color is made possible by a grant from Amersham Life Science, Inc.,
Arlington Heights, Illinois, USA.
kidney. The reason for the generation of these two different sized
transcripts in the kidney is uncertain, but could be related to
message stability, which is known to be affected by differential
poly-A addition [35]. In addition to differences in transcript size,
nucleotide sequence comparisons of the 3' untranslated regions
between the newborn rat kidney clones and mouse and human yl
cDNAs also showed some deviations. Among these is the inser-
tion of three nucleotides in each of two locations in the rat 3'
untranslated region prior to the first AATAAA polyadenylation
signal. Whether any of these differences are functionally impor-
tant also remains to be established.
The in situ hybridization results from fetal rats indicated
prominent expression of the laminin yl chain mRNA in certain
neural structures as well as in the developing gastrointestinal
tract, lung, and kidney. These findings are in general agreement
with earlier immunofluorescence studies that have localized the
yl chain to neural, gastrointestinal, lung and kidney basement
membranes [31, 321. In contrast to an earlier report [36], what the
present in situ hybridization studies show in the lung is that
epithelial cells of developing airways express significantly more
laminin yl chain than the surrounding mesenchyme. In the
kidney, there is maximal expression of yl mRNA by cells within
early glomeruli, although there nevertheless is a persistence of
expression during post-natal glomerular and collecting duct
growth. In view of recent findings on the loss of specific laminin
epitopes from the GBM during glomerular maturation [37],
particularly those on the /31 chain [32], the temporal changes seen
in glomerular laminin are probably not due to major alterations in
synthesis of the yl chain. Instead, synthesis of the /32 chain of
laminin, which initially appears in the GBM at about the time that
/31 declines [32], may signify /3 chain substitution within the GBM,
supporting the concept that laminin isoforms are replaced during
GBM maturation [37]. Our in situ hybridization results shown
here also showed a marked decrease in yl message between
nascent tubules of forming nephrons and elongating tubules
found in the deeper cortex and medulla, These results are also in
good agreement with earlier findings showing an abundance of yl
chain message in RNA obtained from isolated newborn rat
glomeruli and an absence in RNA obtained from newborn tubules
[20]. Perhaps the truncated y chain (y2) recently identified in
human medullary collecting duct [14], or some unidentified y
chain isoform substitutes for yl during tubule maturation after
birth, but this issue needs to be explored further. Alternatively,
maybe the high levels of yl chain synthesis seen during initial
tubulogenesis in embryos provides the full complement of this
chain needed for the TBM.
In summary, previous examinations of the expression patterns
of laminin in the developing kidney have relied heavily on the
premise that the kidney contains laminin corresponding closely to
the EHS laminin-1 prototype but numerous other investigations
have suggested the presence of other laminin isoforms in the
kidney. In the present study, the carboxy terminus of a rat kidney
laminin y chain was cloned and shown to be homologous to the
mouse EHS tumor yl chain. The region of the laminin molecule
represented by the present clones is involved with inter-chain
interaction with al and /31 laminin polypeptides to form the long
arm of the laminin molecule, and this may explain the high degree
of homology seen across species in this domain. In addition, the in
situ hybridization results clearly showed high expression of yl
chain mRNA during early nephron formation. Although relatively
high levels persisted during subsequent glomerular and collecting
duct development, yl synthesis was downregulated in tubules.
The availability of these rat kidney laminin yl cDNAs, along with
the rat laminin /32 clones [12], should provide improved tools for
studying laminin gene expression and protein interactions in the
rat kidney.
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Table 3. TBARS generation by tubular cells incubated with native LDL (200 g) for 24 hours
TBARS nmol MDA/mg protein
—CuSO4 +CuS045 ,.&M
Cell No cell Cell No cell
LDL
LDL + SOD
LDL + ETYA
LDL + L-NAME
LDL + SOD + L-NAME
LEL + ETYA + L-NAME
0
4.32 0.52
0
0
5.63 0.69
0
0.41 0.26
0
0.41 0.26
0
2.24 0.78
0.41 0.26
70.80 2.49
17.36 0.26
70.81 0.52
71.85 0.78
20.49 0.94
70.54 0.52
26.48 2.82
3.28 0.26
25.% 0.69
18.66 0
4.84 1.14
19.44 0.45
dismutase. However, the partial nature of this inhibitory effect
makes it likely that other oxygen free radicals such as hydroxyl
radicals and hydrogen peroxide [55] are also involved. The
latter is a weak oxidant of LDL but its formation is enhanced by
superoxide dismutase [56]; this may account for the small rise in
TBARS noted when LDL was incubated with superoxide
dismutase alone (Table 2).
Clearly, whether or not lipoproteins are oxidized in vivo in
the diseased kidney will depend on the balance between antiox-
idants and pro-oxidants present [57]. In our system as in
previous work, to demonstrate oxidation of LDL by tubular
cells we excluded serum as well as other antioxidants (apart
from transferrin) and added trace amounts of copper [48, 52,
53]. Since a variety of plasma antioxidants and intrinsic renal
antioxidant enzymes are normally present in vivo [57], the
minimal modification of LDL may more closely reflect events
occurring in the diseased kidney. Moreover, the marked oxida-
tive damage which we observed in cells incubated with LDL
and copper (Fig. 6b) is not usually observed in vivo. In this
context, it is particularly striking that high concentrations of
minimally modified LDL (1 mglml) were toxic to confluent
monolayers of human proximal tubular cells and complete cell
detachment from a confluent monolayer seen following incuba-
tion with 2 mg/ml minimally modified LDL (Fig. 2d). Lipopro-
tein uptake appeared to be rapid as the cells were detaching
from their culture surface within 90 minutes, and appeared to be
full of intracellular lipid as demonstrated with oil-red-O staining
(Fig. 2d). In contrast, oxidized LDL caused incomplete cell
detachment from a confluent monolayer at 24 hours even
though the cells that remained attached contained numerous
lipid inclusions (Fig. 2c). It seems likely that this difference is
related to a difference in the mode of uptake of each lipoprotein.
Oxidized LDL is probably taken up by endocytosis and it may
itself inhibit endocytosis by confluent cells [48]. This may in
turn partly limit its toxicity on confluent cell monolayers in
contrast to its effects on subconfluent cells [49]. On the other
hand, minimally modified LDL is recognized by the classical
LDL receptor and is taken up rapidly. Thus, potentially toxic
lipid oxidation products such as lipid peroxides and cholesterol
epoxides [25] may accumulate rapidly at high concentrations
intracellularly and cause cell detachment. This appears to be a
concentration-dependent phenomenon since lower concentra-
tions of minimally modified LDL did not lead to cell detach-
ment.
In summary, we have demonstrated that modified lipopro-
teins are toxic to human renal proximal tubular cells in culture.
Under certain conditions, human renal proximal tubular cells
may also oxidize LDL. In contrast, marked intracellular lipid
accumulation can be generated in tubular cells using high
concentrations of native lipoproteins without causing apparent
cell injury. Thus in nephrosis, one possible scheme by which
filtered lipoproteins might be toxic to proximal tubular cells is
as follows: filtered lipoproteins are taken up by proximal
tubular cells thus generating lipid-laden cells. Depending on the
balance of oxygen radicals generated and anti-oxidants present,
tubular cells may modify LDL. Increased oxygen free radical
production could be a consequence of increased metabolic
work in remnant nephrons (which would also be filtering and
handling lipoprotein) [58] or because of hypoxia [591. Hematu-
ria [60] and transferrinuria [61], being common accompani-
ments of proteinuria, could provide a ready source of iron to
catalyze the oxidative process. Alternatively, LDL may be
oxidized prior to filtration by resident or inflammatory glomer-
ular cells. The toxic effects of oxidized LDL could thus lead to
oxidative tubular injury and the shedding of lipid-laden tubular
cells in nephrotic urine.
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